← Back to Analyst Consensus 
SPTX Buy
Seaport Therapeutics, Inc.
Current Price —
Implied Upside —
Analysts 14
30-Day Momentum
▲ 1 upgrades / ▼ 0 downgrades / 1 reiterations from 2 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 14, 2026 | Canaccord Genuity | initiate | — → Buy | — | 48% |
| Oct 8, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Sep 25, 2026 | Raymond James | initiate | — → Strong Buy | — | 54% |
| Sep 10, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Aug 26, 2026 | Jones Trading | initiate | — → Buy | — | 50% |
| Aug 20, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Aug 4, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Jul 15, 2026 | HC Wainwright & Co. | initiate | — → Buy | — | 44% |
| May 26, 2026 | Citigroup | initiate | — → Buy | — | 54% |
| May 26, 2026 | Leerink Partners | initiate | — → Outperform | — | 51% |
| May 26, 2026 | JP Morgan | initiate | — → Overweight | — | 54% |
| May 26, 2026 | Stifel | initiate | — → Buy | — | 53% |
Price Target Trend
Jun 5, 2026 Latest: $37 Oct 23, 2026
EPS Estimates
0q $-0.56
Lo: $-0.63 Hi: $-0.50
7 analysts ▲2
+1q $-0.60
Lo: $-0.77 Hi: $-0.47
7 analysts ▲2
0y $-5.59
Lo: $-13.10 Hi: $-3.76
7 analysts +1y $-2.52
Lo: $-2.99 Hi: $-1.98
7 analysts ▲1
Cross-Platform Signals
No cross-platform signals in the last 90 days